Related Experiment Video
Updated: Jun 9, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Gentamicin alters nitric oxide production in semicircular canals and otolith organs
Kai Helling1, Ulf-Rüdiger Heinrich, Lukas Heusgen
1Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. kai.helling@ukmainz.de
Objectives/Hypothesis:
Intratympanic application of gentamicin is an important therapeutic option to control vertigo spells in Ménière's disease. Low doses eliminate the function of semicircular canal ampullae (SCCA) and saccule in most patients, although utricular function is maintained in many cases. Local alteration in free radical production might be responsible for these differences. Therefore, the gentamicin-induced nitric oxide (NO) production was determined in an animal model using separate organ cultures of SCCA, saccule, and utricle.
Study Design:
Prospective pilot study in male guinea pigs.
Methods:
SCCA, saccule, and utricle of 28 guinea pigs were isolated and incubated separately for 6 hours in cell culture medium. Gentamicin was administered in two different concentrations (0.4 mg/mL and 0.8 mg/mL) to organ cultures of 16 animals. Tissues from 12 animals were used as controls. Nitric oxide was quantified by chemiluminescence.
Results:
Gentamicin led to an NO increase of about 70% in the saccule, an NO reduction of more than 70% in SCCA, and an NO reduction of 36% in the utricle.
Conclusions:
The selective effects of gentamicin on the NO production in the different sensory areas of the vestibular organ have to be taken into account in the therapy of Ménière's disease.
Insights
Gentamicin selectively alters nitric oxide (NO) production in the vestibular system. This impacts Ménière
Area of Science:
- Vestibular neurobiology
- Ototoxic effects of gentamicin
- Nitric oxide signaling
Background:
- Intratympanic gentamicin is used to manage Ménière's disease vertigo.
- Gentamicin affects semicircular canal ampullae (SCCA) and saccule, sparing the utricle.
- Differential effects may relate to local free radical production.
Purpose of the Study:
- To investigate gentamicin's impact on nitric oxide (NO) production.
- To analyze NO changes in separate vestibular organs (SCCA, saccule, utricle).
- To explore the mechanism behind gentamicin's selective ototoxicity.
Main Methods:
- Prospective pilot study using male guinea pigs.
- Separate organ cultures of SCCA, saccule, and utricle were incubated.
- Gentamicin exposure (0.4 and 0.8 mg/mL) and NO quantification via chemiluminescence.
Main Results:
- Gentamicin increased NO by ~70% in the saccule.
- Gentamicin reduced NO by >70% in SCCA.
- Gentamicin decreased NO by 36% in the utricle.
Conclusions:
- Gentamicin exhibits selective effects on NO production across vestibular organs.
- Understanding these NO alterations is crucial for Ménière's disease therapy.
- This highlights the need to consider NO modulation in gentamicin treatment strategies.
Related Concept Videos
Nitric Oxide Signaling Pathway
The Vestibular System
Inhibitors of Bacterial Protein Synthesis
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Equilibrium and Balance
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

